In other tumor types, MAP4K4 has been implicated in promoting tumor cell invasion and resistance in pancreatic cancer and melanoma through activation of the JNK and RhoA signaling pathways (Li et al., 2015; Gao et al., 2016). The gene discussed is RHOA; the disease is neoplasm.